Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
about
Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression.Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyRole of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenPharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationCYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changesEffect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver MicrosomesCytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide BioactivationCYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with CyclophosphamideStructural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptidesPredictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cellsEffects of fetal bovine serum deprivation in cell cultures on the production of Anticarsia gemmatalis multinucleopolyhedrovirus.Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Baculovirus as versatile vectors for protein expression in insect and mammalian cells.Effect of Host Genetic Variation on the Pharmacokinetics and Clinical Response of Non-nucleoside Reverse Transcriptase Inhibitors.Genetic factors affecting drug disposition in Asian cancer patients.The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteinsMetabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.Effect of renal impairment on the pharmacokinetics of bupropion and its metabolitesSarcomas and pharmacogenetics.Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null miceAntimycotic drug discovery in the age of genomics.Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.The role of genetic variability in drug metabolism pathways in breast cancer prognosis.Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.Interindividual variability of methadone response: impact of genetic polymorphism.RING and coiled-coil domains of baculovirus IE2 are critical in strong activation of the cytomegalovirus major immediate-early promoter in mammalian cells.Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymesDo single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells.Personalized medicine in oncology: tailoring the right drug to the right patient.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.Cytochrome P450 pharmacogenetics in African populations.Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.
P2860
Q24543324-1C89C30A-D381-4C23-B022-752C8204E222Q24676890-5C510090-6125-4D62-B631-190A1D1DA2C7Q26798470-F68BA5B9-A2D0-496D-A6F5-A2621A131DDDQ28083875-3B4BFA45-E046-46B4-BE50-9CDC4D3DE72BQ28535164-DAC08662-07A3-48AE-96F8-A4D396DC6ACBQ28547950-30C19681-A447-4EA3-9251-95913A266166Q28550763-0BDB7DD4-1C09-4B4F-A370-519AA5FD10D5Q28552450-87459B83-0FA9-44B5-A38A-B779C02FA891Q30396630-623B82F1-43D5-464C-AB92-87AF970B683DQ33246815-EC1F3E60-34D8-417F-A712-5AF9B9A5C37FQ33269667-39F5DD1D-60FA-409A-A746-936FE2A11687Q33274596-CA9EDE79-6CC3-4A68-BC22-A4A44EF44153Q33693328-58B3079C-41C7-4859-84F4-494C07FA3E5FQ33747406-B2BE0E5F-0983-4BDB-9631-D90184E4E8A5Q34307873-01F4C34E-6F44-4BC0-83FD-336A05808DE2Q34416430-EE67DC62-BD60-4D00-86FA-F23504EFF50EQ34443184-F39421D1-D42B-4156-960F-F58064127A66Q34501025-7BD6466A-29F6-4328-AB31-67A1005893EFQ34553841-A69D11CC-2DB6-4CF8-959C-516D03796479Q35718630-9F5C0050-08AF-4448-A32A-8ED40F17B21FQ36024598-71DFA503-E439-4C5E-AE8F-26607F6314A4Q36249224-A71C14D3-B55E-4B51-93DE-3C71F2A29125Q36305439-0C3B44BB-FE5A-4E04-A100-D950B039B6ECQ36325362-52C5BD4B-3690-4886-AFD2-CB877AC7F522Q36334753-EE92FB6F-F269-4F26-9D67-B7303C34D45AQ36406247-9E84190A-FC90-46FA-8A0E-C861A3091758Q36497088-FE4EB91B-FD12-4211-A4A5-72F0E5A89DA9Q36802054-0968C1E8-7CCD-482D-B1D6-C61DC6550FD2Q36885659-0FA2EC11-AE6E-4054-A7E0-85FBEFFFF4A2Q36909743-5F3B011A-AF13-48B4-B38D-A6BE92237EABQ37142009-6021E3BE-4CB5-4C69-B0E0-CB707FB7A79DQ37145287-08F87612-78A0-415F-BB5D-1C2D15180696Q37169244-F71BB533-C796-4F36-B559-B699CF61A81CQ37271799-61C934FF-A560-4207-B8D2-5E7ED38E2C4CQ37729202-402A3424-250F-4A0D-92EB-BC2E5A440895Q37779306-326B58F4-20C2-486C-8F37-2D80BCEB2122Q38068541-655322FE-0C25-4312-9D4A-B2B7463912B6Q38099372-DFED365A-3FF2-4B3A-9EDA-28576196FACCQ38878356-29D425C4-237B-492D-AE1C-1CE86B566267Q39173876-F22AF796-C3AD-4A89-A74A-D0E728A4932F
P2860
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@ast
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@en
type
label
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@ast
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@en
prefLabel
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@ast
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@en
P2860
P356
P1476
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
@en
P2093
Andreas Hüser
Christian Hofmann
P2860
P2888
P356
10.1038/SJ.TPJ.6500157
P577
2003-01-01T00:00:00Z